Most Recent Additions*

PDF

Conference Program
Amine Kamen, Tarit Mukhopadhyay, Charles Lutsch, and Nathalie Garçon

PDF

Virus-like particle vaccines against BK and JC polyomaviruses
Diana V. Pastrana, Alberto Peretti, Eileen M. Geoghegan, and Christopher B. Buck

 

Molecular quality engineering for low cost vaccine production
Kerry Routenberg Love, Neil C. Dalvie, J. Christopher Love, and Joseph R. Brady

 

Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapy
Sascha Young Kupke, Dietmar Riedel, Timo Frensing, Pawel Zmora, and Udo Reichl

 

Persistent antibody clonotypes dominate the serum response to influenza following repeated vaccination over multiple years
Jiwon Lee; Andrew P. Horton; Jonathan R. McDaniel; Daniel R. Boutz; Jiwon Jung; Dania A. Hussein; Gregory C. Ippolito; George Georgiou; Philipp Paparoditis,; Alexander Frühwirth; Leontios Pappas; Davide Corti; and Antonio Lanzavecchia

 

Pan-HA antibodies confer protection in mice against influenza
Aziza Manceur, Wangxue Chen, Amalia Ponce, Anne Marcil, Wei Zou, Gilles St-Laurent, Yves Durocher, Mélanie Leclerc, Parminder Chahal, Sven Ansorge, Marie-Hélène Venne, Viktoria Lytvyn, and Rénald Gilbert

 

Accelerating bioprocess development by analysis of all available data: A USP case study
Diego Suarez-Zuluaga, Nicole Driessen, Yvonne Thomassen, Wilfried Bakker, and Daniel Borchert

 

Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates
Pavel Marichal-Gallardo, A. Raquel Fortuna, Yvonne Genzel, Michael Wolff, and Udo Reichl

 

Bioprocess intensification for production of a Peste des petits ruminants virus (PPRV) vaccine
Manuel J.T. Carrondo, Marcos Sousa, Gerhard Greller, Christel Fenge, Jens Rupprecht, and Alexander Tappe

 

Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatography
A. Raquel Fortuna, Florian Taft, Louis Villain, Michael W. Wolff, and Udo Reichl

 

Integrated scalable cyto-technology for recombinant protein bioprocessing
J. Christopher Love, Amos Lu, Kerry R. Love, and Laura Crowell

 

Low-cost cell-based production platform for seasonal and pandemic influenza vaccines
Alan Yung-Chih Hu, Tsai-Chuan Weng, Jenny Bang, and Jessie H.-T. Ni

*Updated as of 09/20/18.